Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The global market for Plasma Albumin was estimated to be worth US$ 5110 million in 2023 and is forecast to a readjusted size of US$ 8367.1 million by 2030 with a CAGR of 7.3% during the forecast period 2024-2030
The plasma albumin market is primarily driven by the increasing demand for albumin in various medical applications. Albumin, a crucial protein found in blood plasma, plays a vital role in maintaining osmotic pressure, transporting nutrients, and regulating pH levels. As a result, it finds extensive use in therapeutic treatments for conditions like hypovolemia, burns, liver cirrhosis, and septic shock. Additionally, the rising prevalence of chronic diseases and surgical procedures further fuels the demand for albumin as a vital component in various medical products and therapies.However, the market also faces challenges, such as the limited availability of human plasma-derived albumin and the strict regulatory guidelines for its collection and purification. Ensuring a stable and adequate supply of albumin can be challenging, especially during times of high demand or unforeseen events. Moreover, the development of alternative albumin sources, such as recombinant human albumin, presents both opportunities and challenges for the market. Overcoming these obstacles through advanced production methods, research, and collaboration within the healthcare industry will be essential in meeting the growing demand and maintaining a sustainable plasma albumin market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Albumin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Plasma Albumin by region & country, by Type, and by Application.
The Plasma Albumin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Albumin.
麻豆原创 Segmentation
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type:
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasma Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Plasma Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Plasma Albumin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Plasma Albumin Product Introduction
1.2 Global Plasma Albumin 麻豆原创 Size Forecast
1.2.1 Global Plasma Albumin Sales Value (2019-2030)
1.2.2 Global Plasma Albumin Sales Volume (2019-2030)
1.2.3 Global Plasma Albumin Sales Price (2019-2030)
1.3 Plasma Albumin 麻豆原创 Trends & Drivers
1.3.1 Plasma Albumin Industry Trends
1.3.2 Plasma Albumin 麻豆原创 Drivers & Opportunity
1.3.3 Plasma Albumin 麻豆原创 Challenges
1.3.4 Plasma Albumin 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Plasma Albumin Players Revenue Ranking (2023)
2.2 Global Plasma Albumin Revenue by Company (2019-2024)
2.3 Global Plasma Albumin Players Sales Volume Ranking (2023)
2.4 Global Plasma Albumin Sales Volume by Company Players (2019-2024)
2.5 Global Plasma Albumin Average Price by Company (2019-2024)
2.6 Key Manufacturers Plasma Albumin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Plasma Albumin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Plasma Albumin
2.9 Plasma Albumin 麻豆原创 Competitive Analysis
2.9.1 Plasma Albumin 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Plasma Albumin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Albumin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 20-25% Concentrations
3.1.2 5% Concentrations
3.2 Global Plasma Albumin Sales Value by Type
3.2.1 Global Plasma Albumin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Plasma Albumin Sales Value, by Type (2019-2030)
3.2.3 Global Plasma Albumin Sales Value, by Type (%) (2019-2030)
3.3 Global Plasma Albumin Sales Volume by Type
3.3.1 Global Plasma Albumin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Plasma Albumin Sales Volume, by Type (2019-2030)
3.3.3 Global Plasma Albumin Sales Volume, by Type (%) (2019-2030)
3.4 Global Plasma Albumin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Therapeutics
4.1.2 Excipient
4.1.3 Other
4.2 Global Plasma Albumin Sales Value by Application
4.2.1 Global Plasma Albumin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Plasma Albumin Sales Value, by Application (2019-2030)
4.2.3 Global Plasma Albumin Sales Value, by Application (%) (2019-2030)
4.3 Global Plasma Albumin Sales Volume by Application
4.3.1 Global Plasma Albumin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Plasma Albumin Sales Volume, by Application (2019-2030)
4.3.3 Global Plasma Albumin Sales Volume, by Application (%) (2019-2030)
4.4 Global Plasma Albumin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Plasma Albumin Sales Value by Region
5.1.1 Global Plasma Albumin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Plasma Albumin Sales Value by Region (2019-2024)
5.1.3 Global Plasma Albumin Sales Value by Region (2025-2030)
5.1.4 Global Plasma Albumin Sales Value by Region (%), (2019-2030)
5.2 Global Plasma Albumin Sales Volume by Region
5.2.1 Global Plasma Albumin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Plasma Albumin Sales Volume by Region (2019-2024)
5.2.3 Global Plasma Albumin Sales Volume by Region (2025-2030)
5.2.4 Global Plasma Albumin Sales Volume by Region (%), (2019-2030)
5.3 Global Plasma Albumin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Plasma Albumin Sales Value, 2019-2030
5.4.2 North America Plasma Albumin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Plasma Albumin Sales Value, 2019-2030
5.5.2 Europe Plasma Albumin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Plasma Albumin Sales Value, 2019-2030
5.6.2 Asia Pacific Plasma Albumin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Plasma Albumin Sales Value, 2019-2030
5.7.2 South America Plasma Albumin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Plasma Albumin Sales Value, 2019-2030
5.8.2 Middle East & Africa Plasma Albumin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Plasma Albumin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Plasma Albumin Sales Value
6.2.1 Key Countries/Regions Plasma Albumin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Plasma Albumin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Plasma Albumin Sales Value, 2019-2030
6.3.2 United States Plasma Albumin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Plasma Albumin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Plasma Albumin Sales Value, 2019-2030
6.4.2 Europe Plasma Albumin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Plasma Albumin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Plasma Albumin Sales Value, 2019-2030
6.5.2 China Plasma Albumin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Plasma Albumin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Plasma Albumin Sales Value, 2019-2030
6.6.2 Japan Plasma Albumin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Plasma Albumin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Plasma Albumin Sales Value, 2019-2030
6.7.2 South Korea Plasma Albumin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Plasma Albumin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Plasma Albumin Sales Value, 2019-2030
6.8.2 Southeast Asia Plasma Albumin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Plasma Albumin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Plasma Albumin Sales Value, 2019-2030
6.9.2 India Plasma Albumin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Plasma Albumin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Grifols
7.1.1 Grifols Company Information
7.1.2 Grifols Introduction and Business Overview
7.1.3 Grifols Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Grifols Plasma Albumin Product Offerings
7.1.5 Grifols Recent Development
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Introduction and Business Overview
7.2.3 CSL Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 CSL Plasma Albumin Product Offerings
7.2.5 CSL Recent Development
7.3 Takeda
7.3.1 Takeda Company Information
7.3.2 Takeda Introduction and Business Overview
7.3.3 Takeda Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Takeda Plasma Albumin Product Offerings
7.3.5 Takeda Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Octapharma Plasma Albumin Product Offerings
7.4.5 Octapharma Recent Development
7.5 CBPO
7.5.1 CBPO Company Information
7.5.2 CBPO Introduction and Business Overview
7.5.3 CBPO Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CBPO Plasma Albumin Product Offerings
7.5.5 CBPO Recent Development
7.6 Hualan Bio
7.6.1 Hualan Bio Company Information
7.6.2 Hualan Bio Introduction and Business Overview
7.6.3 Hualan Bio Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hualan Bio Plasma Albumin Product Offerings
7.6.5 Hualan Bio Recent Development
7.7 Kedrion
7.7.1 Kedrion Company Information
7.7.2 Kedrion Introduction and Business Overview
7.7.3 Kedrion Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Kedrion Plasma Albumin Product Offerings
7.7.5 Kedrion Recent Development
7.8 Shanghai RAAS
7.8.1 Shanghai RAAS Company Information
7.8.2 Shanghai RAAS Introduction and Business Overview
7.8.3 Shanghai RAAS Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Shanghai RAAS Plasma Albumin Product Offerings
7.8.5 Shanghai RAAS Recent Development
7.9 LFB Group
7.9.1 LFB Group Company Information
7.9.2 LFB Group Introduction and Business Overview
7.9.3 LFB Group Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LFB Group Plasma Albumin Product Offerings
7.9.5 LFB Group Recent Development
7.10 Biotest
7.10.1 Biotest Company Information
7.10.2 Biotest Introduction and Business Overview
7.10.3 Biotest Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Biotest Plasma Albumin Product Offerings
7.10.5 Biotest Recent Development
7.11 Tiantan Bio
7.11.1 Tiantan Bio Company Information
7.11.2 Tiantan Bio Introduction and Business Overview
7.11.3 Tiantan Bio Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Tiantan Bio Plasma Albumin Product Offerings
7.11.5 Tiantan Bio Recent Development
7.12 Shuanglin Bio
7.12.1 Shuanglin Bio Company Information
7.12.2 Shuanglin Bio Introduction and Business Overview
7.12.3 Shuanglin Bio Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Shuanglin Bio Plasma Albumin Product Offerings
7.12.5 Shuanglin Bio Recent Development
7.13 Boya Bio
7.13.1 Boya Bio Company Information
7.13.2 Boya Bio Introduction and Business Overview
7.13.3 Boya Bio Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Boya Bio Plasma Albumin Product Offerings
7.13.5 Boya Bio Recent Development
7.14 Yuanda Shuyang
7.14.1 Yuanda Shuyang Company Information
7.14.2 Yuanda Shuyang Introduction and Business Overview
7.14.3 Yuanda Shuyang Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Yuanda Shuyang Plasma Albumin Product Offerings
7.14.5 Yuanda Shuyang Recent Development
7.15 Weiguang Bio
7.15.1 Weiguang Bio Company Information
7.15.2 Weiguang Bio Introduction and Business Overview
7.15.3 Weiguang Bio Plasma Albumin Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Weiguang Bio Plasma Albumin Product Offerings
7.15.5 Weiguang Bio Recent Development
8 Industry Chain Analysis
8.1 Plasma Albumin Industrial Chain
8.2 Plasma Albumin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Plasma Albumin Sales Model
8.5.2 Sales Channel
8.5.3 Plasma Albumin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
听
听
*If Applicable.